Global Iodine Contrast Media Market Growth 2025-2031

The global Iodine Contrast Media market size is predicted to grow from US$ 3871 million in 2025 to US$ 5057 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

Iodinated contrast media are contrast agents that contain iodine atoms used for x-ray-based imaging modalities such as computed tomography (CT). They can also used in fluoroscopy, angiography and venography, and even occasionally, plain radiography. Although the intravenous route of administration is most common, they are also administered by many other routes, including gastrointestinal (oral, rectal), cystourethral, vaginal, intraosseous, etc.

Global key players of iodine contrast media include GE Healthcare, Bracco Imaging, Bayer, Guerbet Group, etc. Global top five manufacturers hold a share over 88%. Asia-Pacific is the largest market of iodine contrast media holds a share over 41%. In terms of product, iohexol is the largest segment, with a share over 31%. And in terms of application, the largest application are hospitals, with a share over 82%.

LP Information, Inc. (LPI) ' newest research report, the “Iodine Contrast Media Industry Forecast” looks at past sales and reviews total world Iodine Contrast Media sales in 2024, providing a comprehensive analysis by region and market sector of projected Iodine Contrast Media sales for 2025 through 2031. With Iodine Contrast Media sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodine Contrast Media industry.

This Insight Report provides a comprehensive analysis of the global Iodine Contrast Media landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iodine Contrast Media portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iodine Contrast Media market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodine Contrast Media and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodine Contrast Media.

This report presents a comprehensive overview, market shares, and growth opportunities of Iodine Contrast Media market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Iohexol
Iodixanol
Iopamidol
Ioversol
Iopromide
Others

Segmentation by Application:
Hospitals
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Bracco Imaging
Bayer
Guerbet Group
Hengrui Medicine
YRPG
BeiLu Pharma
Sanochemia
Imax

Key Questions Addressed in this Report

What is the 10-year outlook for the global Iodine Contrast Media market?

What factors are driving Iodine Contrast Media market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Iodine Contrast Media market opportunities vary by end market size?

How does Iodine Contrast Media break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.